Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.

Tofacitinib taken by mouth helps treat hair loss in children.

Baricitinib was effective in treating both early and late onset alopecia areata.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

Baricitinib works better for alopecia areata in patients not previously treated with tofacitinib.

Tay syndrome is a unique genetic disorder causing skin, hair, and developmental issues.

Iodine-deficient diets and antithyroid substances affected rat growth and behavior, but most adapted with positive weight gain.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Tofacitinib may help regrow hair in alopecia areata patients.

Baricitinib effectively promotes long-term hair regrowth in alopecia areata patients.

AIRE deficiency causes hair loss similar to alopecia areata in mice.

Baricitinib effectively improved skin and hair conditions in a patient with alopecia areata and atopic dermatitis.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Baricitinib is effective and cost-efficient for treating severe alopecia areata in adults.

JAK inhibitors like baricitinib and ritlecitinib are effective new treatments for severe alopecia areata.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

Permanent hair dye may cause total hair loss.

Dupilumab may help children with alopecia areata and atopic dermatitis regrow hair.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

Olumiant should be covered for severe alopecia areata if certain conditions are met.

Farudodstat may help treat alopecia areata by protecting hair follicles.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Activating autophagy in dogs with certain diseases improves their skin and hair.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Acitretin moderately improved skin and eye issues but not hair loss or light sensitivity in a 3-year-old with IFAP syndrome.

A new type of rapid hair loss called ADTA usually gets better on its own within 6 months.